SRI-011381

N/A

Report date: 2025/01/26 19:04:04
NME

Base Information

Drug NameSRI-011381
Drug Alias NameSRI-011381
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta receptors agonistsSmad proteins stimulants
TargetsSmad proteinsTransforming growth factor beta receptors
Therapy Area/IndicationsAlzheimer DiseaseBrain Injuries, TraumaticParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversitySri International
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseBrain Injuries, TraumaticParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A